title: Anti-angiogenic agents in Non-Small-Cell Lung Cancer (NSCLC): a perspective on the MONET1 (Motesanib NSCLC Efficacy and Tolerability) study.
authors.affiliation: VA Palo Alto Health Care System, Palo Alto, CA, USA;
authors.forename: Millie
authors.initials: M
authors.lastname: Das
authors.forename: Heather
authors.initials: H
authors.lastname: Wakelee